Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: Relevance to their toxicities

Toxicology and Applied Pharmacology

Volumn 146, Issue 2, 1997, Pages 227-236

  Katz, Elizabeth J ^a   Cortes, Vania I ^a   Eldefrawi, Mohyee E ^a   Eldefrawi, Amira T ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPYRIFOS; NICOTINIC RECEPTOR; PARAOXON; PARATHION;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DESENSITIZATION; ELECTRIC ORGAN; NONHUMAN; RECEPTOR BINDING; TORPEDO;

EID: 0030726887     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8201     Document Type: Article

References (30)

1. 3. J. Biochem. Tax. 7:1992;125-132.
2. Albuquerque E. X., Kuba K., Daly J. Effect of histrionicotoxin on the ionic conductance modulator of the cholinergic receptor: A quantitative analysis of the end-plate current. J. Pharmacol Exp. Therap. 189:1974;513-524.
3. Arias H. Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor (Review). Mol. Membr. Biol. 13:1996;1-17.
4. 3. J. Biol. Chem. 256:1981;2843-2850.
5. Bakry N. M., El-Rashidy A. H., Eldefrawi A. T., Eldefrawi M. E. Direct actions of organophosphate anticholinesterases on nicotinic and muscarinic acetylcholine receptors. J. Biochem. Toxicol. 3:1988;235-259.
6. Bartels E., Nachmansohn D. Organophosphate inhibitors of acetylcholine-receptor and -esterase tested on the electroplax. Arch. Biochem. Biophys. 133:1969;1-10.
7. Daniel W. W. Biostatistics: A foundation for analysis in the health sciences. Probability and Mathematical Statistics - Applied. 1995;Wiley, New York.
8. 3. J. Pharmacol. Exp. Ther. 221:1982;694-700.
9. Eldefrawi M. E., Aronstam R. S., Bakry N. M., Eldefrawi A. T., Albuquerque E. X. Activation, inactivation and desensitization of acetylcholine receptor channel complex detected by binding of perhydrohistrionicotoxin. Proc. Natl. Acad. Sci. USA. 77:1980a;2309-2313.
10. 3. Proc. Natl. Acad. Sci. USA. 77:1980b;7458-7462.
11. Eldefrawi M. E., Schweizer G., Bakry N. M., Valdes J. J. Desensitization of the nicotinic acetylcholine receptor by diisopropyl-fluorophosphate. J. Biochem. Toxicol. 3:1988;21-32.
12. Ellman G. L., Courtney K. D., Andres V. Jr., Featherstone R. M. A new rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
13. Heidmann T., Changeux J. P. Structural and functional properties of the acetylcholine receptor protein in its purified and membrane-bound states. Ann. Rev. Biochem. 47:1978;317-357.
14. Hucho F., Tsetlin V. I., Machold J. The emerging three-dimensional structure of a receptor. The nicotinic acetylcholine receptor. Eur. J. Biochem. 239:1996;539-557.
15. Huff R. A., Corcoran J. J., Anderson J. K., Abou-Donia M. B. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum. J. Pharm. Exp. Ther. 269:1994;329-335.
16. Huganir R. L., Greengard P. Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron. 5:1990;555-567.
17. Huganir R. L., Delcour A. H., Greengard P., Hess G. P. Phosphorylation of the nicotinic acetylcholine receptor regulates its rate of desensitization. Nature. 321:1986;774-776.
18. Koelle G. B. Pharmacology and toxicology of organophosphates. Clinical and Experimental Toxicology of Organophosphates and Carbamates. 1992;Butterworth-Heinemann, Ltd. Oxford. p. 35-39.
19. Kuba K., Albuquerque E. X., Barnard E. A. Diisopropyl-fluorophosphate: Suppression of ionic conductance of the cholinergic receptor. Science. 181:1974;853-856.
20. Raymon L. P., Mahran L. G., Eldefrawi M. E. Thin layer scintillation counting in drug receptor binding. Anal. Lett. 27:1994;907-918.
21. 125. Eur. J. Pharmacol. 226:1992;56-58.
22. Sakmann B., Patlak J., Neher E. Single acetylcholine-activated channels show burst-kinetics in presence of desensitizing concentrations of agonist. Nature. 286:1980;71-73.
23. Salpeter M. M., Eldefrawi M. E. Sizes of endplate compartments, densities of ACh receptors and other quantitative aspects of neuromuscular transmission. J. Histochem. Cytochem. 21:1973;769-778.
24. Sherby S. M., Eldefrawi A. T., Albuquerque E. X., Eldefrawi M. E. Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor. Mol. Pharmacol. 27:1985;343-348.
25. 2. Toxicol. Appl. Pharmacol. 103:1990;474-481.
26. Tattersall J. E. Effects of organophosphorus anticholinesterases on the nicotinic receptor ionic channels at adult mouse muscle endplates. Br. J. Pharmacol. 101:1990;349-357.
27. Taylor P. Anticholinesterase agents. Gilman A. G. Goodman and Gilman's, The Pharmacological Basis of Therapeutics. 1990;131-149 Pergamon, New York.
28. Tsai M-.C., Mansour N. A., Eldefrawi A. T., Eldefrawi M. E., Albuquerque E. X. Mechanisms of action of amantadine on neuromuscular transmission. Mol. Pharmacol. 14:1978;787-803.
29. Van De Kamp J. L., Collins A. C. Species differences in diisopropylfluorophosphate-induced decreases in the number of brain nicotinic receptors. Pharm. Biochem. Behav. 42:1992;131-141.
30. Weiland G., Georgia B., Lappi S., Chignell C. F., Taylor P. Kinetics of agonist-mediated transition state of the cholinergic receptor. J. Biol. Chem. 252:1977;7648-7656.